Did you know?

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) announced its quarterly earnings results on Thursday, February, 15th. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.03. The biotechnology company had revenue of $45.10 million for the quarter, compared to ...Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Message Board. Share and engage with a community of investors on the fastest growing stock message board.52 week high is the highest price of a stock in the past 52 weeks, or one year. Aurinia Pharmaceuticals Inc 52 week high is $12.43 as of May 08, 2024.Should you use a heat gun to dry paint in the cold weather? Visit HowStuffWorks.com to learn if you should use a heat gun to dry paint in the cold weather. Advertisement When paint... N/A. In depth view into AUPH (Aurinia Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value. May. 07. CI. Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024. May. 02. Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Revenue $50.3M, vs. Street Est of $47.1M. May. 02.News for AUPH. View Aurinia Pharmaceuticals Inc AUPH investment & stock information. Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats ...The latest price target for Aurinia Pharmaceuticals ( NASDAQ: AUPH) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 13.00 expecting AUPH to ...Far from elitist and urban. India’s #MeToo movement, run down as elitist and urban by critics, may not be so after all. For around three weeks now, a number of Indian women, partic...Founded in 2012, Aurinia Pharmaceuticals Inc specializes in principled drug development and commercialization in the field of autoimmune diseases. The Canadian company’s stocks are currently valued at $14.33 (as of 23 August 2021), and the values are projected to rise with the impending acquisition.Previous Close $5.09. Volume 984.06K. Average Volume (3M) 2.09M. Market Cap. $736.10M. Enterprise Value $483.22M. Total Cash (Recent Filing) $350.49M. Total Debt (Recent Filing) $97.61M. Price to Earnings (P/E) -9.3.Aurinia Pharmaceuticals (AUPH) announces the issue of its new and refined method-of-use patent, supplementing its existing patent, for Lupkynis to treat lupus nephritis. Shares are up 11%.ALT. 7.22. -6.48%. Find out all the key statistics for Aurinia Pharmaceuticals Inc. (AUPH), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.Based on recent acquisitions, Aurinia ( AUPH) would be more likely to see $18–$20 per share in a takeover, RBC analyst Douglas Miehm, who has an outperform rating with a $13 price target on AUPH ...ABOUT US. The Aurinia logo is a modern representation of the lotus flower, a symbol of life and health. Like the lotus, we are resilient in our efforts to develop breakthrough treatments that become the gold standard of patient care, enabling patients to live their fullest lives. At Aurinia, we embrace the possibility to change the trajectory ... Please be reminded that iHub limits members to a single account. You can recover your Login credentials using either your alias or registered email address. If you need further assistance such as changing your alias, please fill out a Support Request . In a report released on March 1, Joseph Schwartz from SVB Securities reiterated a Buy rating on Aurinia Pharmaceuticals (AUPH – Research R... In a report released on March 1,...Yup. iHub can't get rid of "Biotech Researcher," aka BR. It's both a win for BR (the troll), and a huge loss for iHub. Their platform loses value and credibility when they refuse to take action on perma-trolls that derail the discussion and distract investors from their efforts to just honestly share information and opinions on the equities they own.Get Aurinia Pharmaceuticals Inc (AUPH.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAnnual Pre -Tax Margin. -44.1%. Sector. medical. Industry Group. Medical-Biomed/Biotech. Industry Group Rank. 23. AUPH, Aurinia Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines.5.12. -0.78%. You can practice and explore trading AUPH stock methods without spending real money on the virtual paper trading platform. Webull offers AUPH Ent Holdg (AUPH) historical stock prices, in-depth market analysis, NASDAQ: AUPH real-time stock quote data, in-depth charts, free AUPH options chain data, and a fully built financial ...Current Price. $5.01. Options. Research & Ratings. Notes & Data Providers. Aurinia Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AUPH updated stock ...4 analysts have issued 1 year target prices for Aurinia Pharmaceuticals' shares. Their AUPH share price targets range from $8.00 to $13.00. On average, they predict the company's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 94.9% from the stock's current price.

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Message Board. Share and engage with a community of investors on the fastest growing stock message board.For fiscal 2023, the company expects LUPKYNIS revenue to be between $120 million and $140 million, representing annual growth of 15.4% to 34.6% in terms of net product sales. While analysts expect ... Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada. income statement | balance sheet | cash flow. View the latest Aurinia Pharmaceuticals Inc. (AUPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.See the company profile for Aurinia Pharmaceuticals Inc. (AUPH) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ...

In a report released yesterday, Prasath Pandurangan from Bloom Burton maintained a Buy rating on Aurinia Pharmaceuticals (AUPH – Research ... In a report released yesterday, ...Recent AUPH News. Form 4 - Statement of changes in beneficial ownership of securities • Edgar ... InvestorsHub community. Register for free to join our community of investors and share your ideas. You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow ...Track Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. The latest Aurinia Pharmaceuticals stock pr. Possible cause: Financial Overview. AUPH had net product revenue of $42.3M in Q4'23, and reaffi.